The liver malignant neoplasms mortality rate among women in the US is showing a consistent upward trend from 2024 to 2028, with annual increases reaching 6.5 deaths per hundred thousand women by 2028. The forecasted figures indicate a steady year-on-year growth rate of approximately 1.6%. This trend is mirrored in the compounded annual growth rate (CAGR) over five years, suggesting a gradual but persistent rise in mortality rates.

Future trends to watch for include:

The impact of medical advancements in early detection and treatment.
The influence of public health initiatives aimed at reducing risk factors like obesity and alcohol consumption.
Potential changes in healthcare policies affecting access to liver cancer treatments for women.